Targeted News Service

MD Anderson And Exscientia Launch Strategic Collaboration To Leverage AI In Developing Novel Oncology Treatments
November 15, 2022

HOUSTON, Texas, Nov. 15 (TNSpar) -- The University of Texas's MD Anderson Cancer Center issued the following news release on Nov. 14, 2022:

The University of Texas MD Anderson Cancer Center and Exscientia plc today announced a strategic collaboration to align the drug discovery and development expertise of MD Anderson with the patient-centric artificial intelligence (AI) capabilities of Exscientia in order to advance novel small-molecule oncology therapies.

The res . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form